Product Program year 2025 Source: CMS Open Payments

ReCross

Device Cardiology/Vascular Diseases

PDI 08718481740309

Open in the dashboard

General payments

$80,019

412 payments

Research payments

$0

0 payments

Through program year 2025, $80,019 in general payments and $0 in research payments were reported against ReCross (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $9,540 42
2024 General $30,418 198
2023 General $40,061 172

Breakdown

Who paid General payments · program years 2023–2025
  1. Biotronik Inc. $80,019 412 payments
Top recipients General payments · program year 2025
  1. Ajay Kirtane Interventional Cardiology · New York, NY $5,332 56% · 2 payments
  2. Reza Nazari Cardiovascular Disease · Turlock, CA $363 4% · 5 payments
  3. Garrett Wong Cardiovascular Disease · Sacramento, CA $363 4% · 5 payments
  4. Jasvindar Singh Interventional Cardiology · Saint Louis, MO $205 2% · 1 payment
  5. Charles Shoultz Cardiovascular Disease · Waco, TX $181 2% · 1 payment

The top 5 of 32 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $7,090 75% · 14 practitioners
  2. Cardiovascular Disease Internal Medicine $2,156 23% · 14 practitioners
  3. Physician Assistant $108 1% · 1 practitioner
  4. Vascular Surgery Surgery $78 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. New York $5,604 59% · 3 recipients
  2. California $1,801 19% · 12 recipients
  3. Texas $595 6% · 6 recipients
  4. Missouri $567 6% · 3 recipients
  5. Florida $221 2% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

412 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record